Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 February 2020 : Clinical Research  

Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III–IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004–2014

San-Gang Wu1ABC, Feng-Yan Li2AE, Jian Lei3F, Li Hua3F, Zhen-Yu He3AE, Juan Zhou3ABCG*

DOI: 10.12659/MSM.920531

Med Sci Monit 2020; 26:e920531

Abstract

BACKGROUND: The prognosis of epithelial ovarian cancer (EOC) remains poor. Cause-specific survival (CSS) is an overall survival measure of cancer survival that excludes other causes of death. This retrospective population study used the Surveillance, Epidemiology, and End Results (SEER) database to evaluate prognostic factors associated with one-year CSS in women with stage III–IV EOC between 2004–2014.

MATERIAL AND METHODS: Data from the SEER program included a cohort of patients with stage III–IV EOC between 2004–2014. Binomial logistic regression analysis, Kaplan-Meier survival curves, and multivariate Cox proportional hazards models were used for analysis of patient outcome, including the one-year CSS.

RESULTS: There were 14,798 patients with stage III–IV EOC identified from SEER between 2004–2014, including 13,134 (88.8%), 892 (6.0%), 448 (3.0%), and 324 (2.2%) patients with serous, endometrioid, clear cell, and mucinous ovarian cancer, respectively. The overall one-year CSS was 91.2%. One-year CSS was 92.5%, 92.2%, 74.0%, and 62.5% in patients with serous, endometrioid, clear cell, and mucinous ovarian cancer, respectively (P<0.001). Histological tumor type was an independent prognostic factor of one-year CSS. Patients with mucinous EOC (HR, 8.807; 95% CI, 6.563–9.965; P<0.001) and clear cell EOC (HR, 4.581; 95% CI, 3.774–5.560; P<0.001) had a significantly lower one-year CSS compared with patients with endometrioid and serous EOC who had comparable one-year CSS (HR, 1.247; 95% CI, 0.978–1.590; P=0.075).

CONCLUSIONS: A retrospective population study of the SEER database between 2004–2014 identified that histological tumor type was associated with one-year CSS in women with stage III–IV EOC.

Keywords: Histology, Mortality, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Databases as Topic, Multivariate Analysis, Proportional Hazards Models, SEER Program, Time Factors

Add Comment 0 Comments

Editorial

01 September 2024 : Editorial  

Editorial: Reasons for Increasing Global Concerns for the Spread of Mpox

Dinah V. Parums

DOI: 10.12659/MSM.946343

Med Sci Monit 2024; 30:e946343

0:00

In Press

Review article  

Long COVID or Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and the Urgent Need to Identify Diagnostic...

Med Sci Monit In Press; DOI: 10.12659/MSM.946512  

Clinical Research  

Intravenous Lidocaine Response as a Predictor for Oral Oxcarbazepine Efficacy in Neuropathic Pain Syndrome:...

Med Sci Monit In Press; DOI: 10.12659/MSM.945612  

Review article  

Cariprazine in Psychiatry: A Comprehensive Review of Efficacy, Safety, and Therapeutic Potential

Med Sci Monit In Press; DOI: 10.12659/MSM.945411  

Clinical Research  

Comparison of Remimazolam and Dexmedetomidine for Sedation in Awake Endotracheal Intubation in Scoliosis Su...

Med Sci Monit In Press; DOI: 10.12659/MSM.944632  

Most Viewed Current Articles

17 Jan 2024 : Review article   6,053,124

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research   1,840,708

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   693,001

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

07 Jan 2022 : Meta-Analysis   257,439

Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...

DOI :10.12659/MSM.935074

Med Sci Monit 2022; 28:e935074

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750